Aoti, Inc. is engaged in wound care technology around the world. The Company is focused on helping all people with chronic conditions get back to living their lives to the fullest. It does this by enhancing access to care, improving clinical outcomes and quality of life, and advancing health equity. Its products are built with integrity and backed by robust clinical evidence, ensuring safety and efficacy for its patients. Its solutions include Topical Wound Oxygen (TWO2) and NEXA Negative Pressure Wound Therapy (NPWT). TWO2 therapy is a multi-modality patient-administered therapy. TWO2 is a clinically proven therapy for the treatment of chronic and difficult-to-heal wounds. The NEXA NPWT System is a multi-week, multi-patient, disposable system that delivers the performance and flexibility of traditional NPWT systems. TWO2 therapy solutions include TWO2 Extremity Chamber and TWO2 Multi-Patch.

Employees

-

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
17/01/25	120.00 p	0.00%	0
16/01/25	120.00 p	0.00%	0
15/01/25	120.00 p	+7.14%	356,018
14/01/25	112.00 p	+2.75%	1,110,111
13/01/25	109.00 p	0.00%	0

Delayed Quote London S.E., January 17, 2025 at 07:59 am

More quotes

Income Statement and Estimates

income-statement-evolution-chart AOTI-INC

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.200GBP

Average target price

1.690GBP

Spread / Average Target

+40.83%

Consensus

Profit revisions

Estimate revisions

Annual profits - Rate of surprise

Company calendar

Market Closed - London S.E. Other stock markets 16:35:27 17/01/2025 GMT			5-day change	1st Jan Change
120.00 ^GBX	0.00%		+10.09%	+8.11%

01-09	MedTech Aoti Expands Medicaid Coverage in US	MT
12-17	Certain Options of AOTI, Inc. are subject to a Lock-Up Agreement Ending on 18-DEC-2024.	CI

Capitalization	156M 152M 142M 128M 225M 13.52B 251M 1.74B 647M 5.53B 586M 574M 24.25B	P/E ratio 2024 *	-	P/E ratio 2025 *	19.2x
Enterprise value	158M 153M 144M 129M 227M 13.66B 254M 1.76B 653M 5.59B 592M 579M 24.5B	EV / Sales 2024 *	2.72x	EV / Sales 2025 *	2.14x
Free-Float	34.42%	Yield 2024 *	-	Yield 2025 *	-

MedTech Aoti Expands Medicaid Coverage in US	01-09	MT
Certain Options of AOTI, Inc. are subject to a Lock-Up Agreement Ending on 18-DEC-2024.	12-17	CI
Certain Common Shares of AOTI, Inc. are subject to a Lock-Up Agreement Ending on 18-DEC-2024.	12-17	CI
Aoti Begins Patient Enrollment in Clinical Trial of Chronic Venous Leg Ulcer Therapy	12-16	MT
AOTI, Inc. Receives Five Year Extension to Veterans Administration Contract	12-12	CI
Peel Hunt swings to profit as IPO market "gradually" restarts	11-29	AN
Peel Hunt swings to profit as London IPO market "gradually" restarts	11-29	AN
AOTI confident in outlook as interim loss widens amid higher costs	16/09/24	AN
AOTI says trading picks up in second quarter	15/08/24	AN
AOTI, Inc. Provides Revenue Guidance for the Six Months Ended 30 June 2024 and Full Year 2024	15/08/24	CI
Aoti's Wound Care Device Wins US FDA Approval for Home Care Settings	29/07/24	MT
AOTI, Inc. Announces US FDA 510(k) Clearance of NEXATM NPWT System	29/07/24	CI
AOTI raises GBP35 million as debuts on AIM market	18/06/24	AN

1 week	+10.09%
Current month	+8.11%
1 month	+4.35%
3 months	-9.43%
6 months	-11.11%
Current year	+8.11%

AOTI, Inc. Share Price

Equities

AOTI

US03690C1027

Medical Equipment, Supplies & Distribution

Valuation: AOTI, Inc.

Chart: AOTI, Inc.

Latest news: AOTI, Inc.

Quotes and Performance

Course Extremes

Medical Equipment

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Annual profits - Rate of surprise

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
AOTI, INC.	0.00%	+10.09%	-	-	156M
SHOCKWAVE MEDICAL	-0.01%	+0.01%	+54.16%	+100.50%	12.57B
PENUMBRA, INC.	+0.21%	+1.75%	-0.29%	+10.41%	10.07B
MASIMO CORPORATION	-1.24%	+0.68%	+41.50%	-27.09%	9.1B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+0.60%	+3.54%	+2.34%	-0.06%	4.84B
INARI MEDICAL, INC.	0.00%	+0.13%	+34.76%	+1.94%	4.65B
GETINGE AB	+1.36%	+2.33%	-12.39%	-42.71%	4.66B
APT MEDICAL INC.	+4.32%	+7.41%	+43.86%	+124.88%	4.77B
ASAHI INTECC CO., LTD.	+0.51%	-1.64%	-16.04%	+17.28%	4.32B
NOVOCURE LIMITED	-1.25%	-10.00%	+106.67%	-62.36%	2.82B
Average	+0.45%	+1.32%	+28.29%	+13.64%	5.8B
Weighted average by Cap.	+0.33%	+0.85%	+27.87%	+24.67%

	2024 *	2025 *
Net sales	58.1M 56.44M 52.94M 47.49M 83.64M 5.03B 93.41M 647M 241M 2.06B 218M 213M 9.02B	76.7M 74.51M 69.89M 62.69M 110M 6.64B 123M 855M 318M 2.72B 288M 282M 11.91B
Net income	-1.8M -1.75M -1.64M -1.47M -2.59M -156M -2.89M -20.06M -7.46M -63.78M -6.75M -6.61M -280M	8.3M 8.06M 7.56M 6.78M 11.95M 719M 13.34M 92.49M 34.38M 294M 31.14M 30.49M 1.29B
Net Debt	1.6M 1.55M 1.46M 1.31M 2.3M 139M 2.57M 17.83M 6.63M 56.7M 6M 5.88M 248M	7.7M 7.48M 7.02M 6.29M 11.08M 667M 12.38M 85.8M 31.89M 273M 28.89M 28.28M 1.2B